FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1685-1687 May 27, 1999 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kelsen, D. P. PubMed Citation

To the Editor: The negative result obtained by Kelsen et al. in their trial of preoperative chemotherapy for operable esophageal cancer (Dec. 31 issue)¹ is somewhat surprising, since Herskovic et al.² reported positive results for similar chemotherapy with or without radiation therapy. Patient accrual in the study by Kelsen et al. was meager (average, <1 patient per hospital per year). How did the study centers maintain high clinical quality, given the low accrual rate? Were there any differences between the centers that were major contributors of data and the rest of the hospitals? Our own results lead us to believe . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Beer, A. J., Wieder, H. A., Lordick, F., Ott, K., Fischer, M., Becker, K., Stollfuss, J., Rummeny, E. J. (2006). Adenocarcinomas of Esophagogastric Junction: Multi-Detector Row CT to Evaluate Early Response to Neoadjuvant Chemotherapy. Radiology 239: 472-480 [Abstract] [Full Text]  
• Voelter, V., Schuhmacher, C., Busch, R., Peschel, C., Siewert, J. R., Lordick, F. (2004). Incidence of anemia in patients receiving neoadjuvant chemotherapy for locally advanced esophagogastric cancer. Ann. Thorac. Surg. 78: 1037-1041 [Abstract] [Full Text]